CD10 is a diagnostic and prognostic marker in renal malignancies
Article first published online: 20 OCT 2004
Volume 45, Issue 5, pages 460–467, November 2004
How to Cite
Langner, C., Ratschek, M., Rehak, P., Schips, L. and Zigeuner, R. (2004), CD10 is a diagnostic and prognostic marker in renal malignancies. Histopathology, 45: 460–467. doi: 10.1111/j.1365-2559.2004.01982.x
- Issue published online: 20 OCT 2004
- Article first published online: 20 OCT 2004
- Date of submission 11 November 2003 Accepted for publication 26 February 2004
- differential diagnosis;
- renal cell carcinoma;
- transitional cell carcinoma
Aims: To determine the diagnostic and prognostic value of CD10 immunoreactivity in renal cell carcinomas (RCCs) and transitional cell carcinomas (TCCs).
Methods and results: CD10 expression was investigated in primary (n = 180) and metastatic (n = 58) RCCs and upper urinary tract TCCs (n = 53) using a tissue microarray technique. One hundred and fifty-four of 172 (90%) evaluable primary and 48/56 (86%) evaluable metastatic RCCs expressed CD10. Extensive immunoreactivity (positivity of >50% cancer cells) decreased with rising tumour grade in conventional RCCs [G1/G2 72/81 (89%), G3/G4 33/48 (69%); P = 0.009]. Chromophobe RCCs showed a significantly lower overall and extensive immunoreactivity compared with conventional tumours (P < 0.001). In papillary RCCs immunoreactivity of more than 10% of cancer cells for CD10 was seen more often in type 2 (7/8, 88%) compared with type 1 (5/12, 42%; P =0.054) tumours. In conventional RCCs, pure apical membranous staining was associated with low tumour stage (P = 0.003), low grade (P = 0.004) and improved prognosis on univariate analysis (P = 0.031). TCCs were less frequently stained (51%). Extensive staining, however, was associated with high-stage tumours (P = 0.024), high-grade (P = 0.073) tumours, and was associated with shorter disease-free survival in univariate analysis (P = 0.003).
Conclusions: CD10 proved to be an additional marker for renal malignancies with predominantly diagnostic potential.